13F
← All fund report cards

ASPIRIANT, LLC

13F equity value
$3.5B
Positions
338
Top 10 concentration
64.0%
Quarters / total new picks
32 / 366
13F equity value over time
$0M$2B$4B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.36, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.0%
t-stat
0.36
Quarterly win rate
56%
Annualized excess
+1.9%
$1 → follow vs universe
$2.40 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.04920180630: follow 1.00120180930: follow 0.97820181231: follow 1.01520190331: follow 1.04420190630: follow 1.14320190930: follow 1.16120191231: follow 0.87720200331: follow 0.91220200630: follow 1.02120200930: follow 1.26520201231: follow 1.46720210331: follow 2.00020210630: follow 1.96320210930: follow 1.61220211231: follow 1.46720220331: follow 1.44620220630: follow 1.35920220930: follow 1.54320221231: follow 1.57820230331: follow 1.69620230630: follow 1.66220230930: follow 1.78820231231: follow 1.85920240331: follow 1.89520240630: follow 2.12920240930: follow 2.17520241231: follow 2.45220250331: follow 2.42720250630: follow 2.43520250930: follow 2.37120251231: follow 2.399 0.81 1.73 2.65 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 338 · 2026 Q1

Ticker Value Weight QoQ
IVV $432M
12.3%
ADD
VBR $378M
10.8%
ADD
IUSV $377M
10.7%
ADD
ACWV $291M
8.3%
HOLD
VTEB $211M
6.0%
HOLD
VIG $205M
5.9%
HOLD
VOO $108M
3.1%
HOLD
IEFA $89M
2.5%
ADD
EFV $80M
2.3%
HOLD
IEMG $75M
2.1%
HOLD
AAPL $69M
2.0%
TRIM
IWB $40M
1.1%
HOLD
BND $40M
1.1%
ADD
SPY $38M
1.1%
HOLD
BRK/B $35M
1.0%
ADD
DFUV $34M
1.0%
HOLD
FBND $34M
1.0%
HOLD
AOR $33M
0.9%
ADD
VIOV $31M
0.9%
HOLD
MUB $31M
0.9%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.